Free Trial

Marpai (MRAI) Competitors

Marpai logo
$1.40 +0.04 (+2.94%)
As of 07/11/2025 03:43 PM Eastern

MRAI vs. QIPT, NAKA, KDLY, ATPC, CORBF, OPGN, PIII, BDSX, BNR, and BMGL

Should you be buying Marpai stock or one of its competitors? The main competitors of Marpai include Quipt Home Medical (QIPT), KindlyMD (NAKA), Kindly MD (KDLY), Agape ATP (ATPC), Global Cord Blood (CORBF), OpGen (OPGN), P3 Health Partners (PIII), Biodesix (BDSX), Burning Rock Biotech (BNR), and Basel Medical Group (BMGL). These companies are all part of the "healthcare" industry.

Marpai vs. Its Competitors

Quipt Home Medical (NASDAQ:QIPT) and Marpai (NASDAQ:MRAI) are both small-cap healthcare companies, but which is the superior investment? We will contrast the two businesses based on the strength of their earnings, profitability, analyst recommendations, valuation, institutional ownership, media sentiment, dividends and risk.

Quipt Home Medical has a beta of 0.56, suggesting that its stock price is 44% less volatile than the S&P 500. Comparatively, Marpai has a beta of 4.68, suggesting that its stock price is 368% more volatile than the S&P 500.

Quipt Home Medical has a net margin of -3.66% compared to Marpai's net margin of -85.70%. Marpai's return on equity of 0.00% beat Quipt Home Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Quipt Home Medical-3.66% -8.38% -3.63%
Marpai -85.70%N/A -100.23%

Quipt Home Medical has higher revenue and earnings than Marpai. Quipt Home Medical is trading at a lower price-to-earnings ratio than Marpai, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Quipt Home Medical$245.91M0.33-$6.76M-$0.21-8.90
Marpai$34.87M0.66-$28.75M-$1.82-0.77

Quipt Home Medical currently has a consensus price target of $2.85, suggesting a potential upside of 52.41%. Given Quipt Home Medical's stronger consensus rating and higher possible upside, research analysts clearly believe Quipt Home Medical is more favorable than Marpai.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Quipt Home Medical
0 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
1 Strong Buy rating(s)
3.00
Marpai
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

42.9% of Quipt Home Medical shares are owned by institutional investors. Comparatively, 49.8% of Marpai shares are owned by institutional investors. 13.4% of Quipt Home Medical shares are owned by company insiders. Comparatively, 61.3% of Marpai shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

In the previous week, Quipt Home Medical had 13 more articles in the media than Marpai. MarketBeat recorded 13 mentions for Quipt Home Medical and 0 mentions for Marpai. Quipt Home Medical's average media sentiment score of 0.64 beat Marpai's score of 0.00 indicating that Quipt Home Medical is being referred to more favorably in the media.

Company Overall Sentiment
Quipt Home Medical Positive
Marpai Neutral

Summary

Quipt Home Medical beats Marpai on 11 of the 17 factors compared between the two stocks.

Get Marpai News Delivered to You Automatically

Sign up to receive the latest news and ratings for MRAI and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding MRAI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

MRAI vs. The Competition

MetricMarpaihealth & allied services, not elsewhere classified IndustryBusiness SectorNASDAQ Exchange
Market Cap$23.15M$68.49M$15.36B$9.09B
Dividend YieldN/AN/A2.72%4.02%
P/E Ratio-0.530.5928.6920.26
Price / Sales0.660.40430.14151.97
Price / CashN/A2.8026.3457.67
Price / Book-0.810.126.185.49
Net Income-$28.75M$43.11M$190.21M$250.45M
7 Day Performance3.70%-30.95%0.97%4.79%
1 Month Performance0.72%-18.81%6.08%9.59%
1 Year Performance86.68%3.89%28.16%16.41%

Marpai Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
MRAI
Marpai
N/A$1.40
+2.9%
N/A+86.7%$23.15M$34.87M-0.53150Gap Up
QIPT
Quipt Home Medical
3.1767 of 5 stars
$1.80
+4.0%
$2.85
+58.3%
-37.0%$75.16M$245.91M-8.571,200Analyst Revision
NAKA
KindlyMD
N/A$12.91
+7.2%
N/AN/A$72.60M$2.72M-16.77N/AGap Up
KDLY
Kindly MD
N/A$12.04
-5.6%
N/A+412.5%$72.51M$2.47M-15.64N/AGap Up
ATPC
Agape ATP
0.5449 of 5 stars
$1.39
-0.5%
N/A-62.8%$69.76M$1.32M-2.3140News Coverage
Gap Down
CORBF
Global Cord Blood
N/A$0.55
+0.1%
N/AN/A$66.91M$196.12M0.001,200
OPGN
OpGen
N/A$4.93
-1.8%
N/A+49.4%$49.64M$2.67M0.00100
PIII
P3 Health Partners
3.3946 of 5 stars
$6.10
-4.7%
$16.25
+166.4%
-76.9%$46M$1.50B-0.13500Positive News
BDSX
Biodesix
4.0973 of 5 stars
$0.29
+6.6%
$1.75
+495.2%
-81.7%$40.42M$71.32M-1.01220Positive News
Gap Up
BNR
Burning Rock Biotech
1.4633 of 5 stars
$3.70
+3.9%
N/A-32.8%$38.31M$70.67M-1.961,390Positive News
BMGL
Basel Medical Group
N/A$1.82
-5.2%
N/AN/A$35.43MN/A0.0036Positive News

Related Companies and Tools


This page (NASDAQ:MRAI) was last updated on 7/13/2025 by MarketBeat.com Staff
From Our Partners